VerAvanti is the vision of Gerald McMorrow who is/was the Founder & CEO of Verathon Inc. which sold to Roper Technologies for $300M. VVerAvanti is pioneering the only forward-looking, real-time intravascular imaging technology. With 50+ patents and a projected $380M revenue by 2029, Veravanti is positioned to disrupt a $5.5B market. Our technology enhances precision in stroke, heart disease, and CTO treatments, solving a $120B+ unmet need. stroke, heart disease, and CTO treatments, solving a $120B+ unmet need.